Francesco Curcio Selected Research

Hypothyroidism

6/2013	Effects of ultraviolet radiation on FRTL-5 cell growth and thyroid-specific gene expression.
3/2009	Influence of iodide excess and interferon-gamma on human primary thyroid cell proliferation, thyroglobulin secretion, and intracellular adhesion molecule-1 and human leukocyte antigen-DR expression.
6/2003	Thyrotropin stimulates production of procoagulant and vasodilative factors in human aortic endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Curcio Research Topics

Disease

28	COVID-19 11/2023 - 01/2020
17	Neoplasms (Cancer) 06/2022 - 09/2003
14	Infections 12/2023 - 11/2011
7	Inflammation (Inflammations) 01/2023 - 03/2006
5	Frailty 04/2022 - 01/2018
4	Dementia (Dementias) 01/2020 - 01/2016
3	Orthostatic Hypotension (Postural Hypotension) 12/2024 - 01/2018
3	Respiratory Insufficiency (Respiratory Failure) 06/2023 - 01/2021
3	Sepsis (Septicemia) 08/2022 - 01/2021
3	Pneumonia (Pneumonitis) 09/2021 - 01/2020
3	Necrosis 01/2021 - 12/2007
3	Heart Failure 01/2020 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2016
3	Sarcopenia 01/2018 - 01/2015
3	Thyroid Neoplasms (Thyroid Cancer) 04/2017 - 07/2006
3	Lymphoma (Lymphomas) 01/2015 - 12/2007
3	Hypothyroidism 06/2013 - 06/2003
3	Rheumatoid Arthritis 03/2012 - 11/2010
2	Reinfection 12/2023 - 12/2021
2	Obesity 10/2022 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 08/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2007
2	Cytokine Release Syndrome 01/2022 - 01/2020
2	Insulin Resistance 01/2022 - 04/2013
2	Hematologic Neoplasms (Hematological Malignancy) 08/2021 - 01/2016
2	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2006
2	Syncope (Fainting) 01/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 08/2019 - 05/2007
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 11/2018 - 07/2015
2	Cognitive Dysfunction 01/2017 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2016 - 01/2015
2	Arthritis (Polyarthritis) 01/2015 - 11/2011
2	Papillary Thyroid Cancer 05/2006 - 03/2004
1	Chronic Renal Insufficiency 12/2024
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Stroke (Strokes) 09/2022
1	Ischemic Stroke 09/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2022
1	Pulmonary Embolism 06/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2022

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2008
9	CytokinesIBA 01/2023 - 01/2017
9	AntibodiesIBA 10/2022 - 11/2010
9	Proteins (Proteins, Gene)FDA Link 08/2022 - 05/2006
7	Interleukin-6 (Interleukin 6)IBA 08/2022 - 03/2012
6	Immunoglobulin M (IgM)IBA 12/2023 - 10/2021
6	Immunoglobulin G (IgG)IBA 12/2023 - 10/2021
5	hydroxide ionIBA 12/2024 - 01/2018
5	LipidsIBA 11/2018 - 10/2014
4	Messenger RNA (mRNA)IBA 04/2023 - 07/2006
4	Rituximab (Mabthera)FDA Link 01/2022 - 01/2008
4	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2020 - 07/2015
4	SphingomyelinsIBA 05/2017 - 01/2015
3	VaccinesIBA 02/2023 - 09/2021
3	belimumabIBA 01/2023 - 08/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2003
3	Oxygen (Dioxygen)IBA 09/2021 - 05/2020
3	Cholecalciferol (Vitamin D3)FDA Link 08/2021 - 01/2016
3	ProcalcitoninIBA 02/2021 - 01/2019
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 03/2018 - 01/2016
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2018 - 01/2016
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018 - 01/2016
3	AutoantibodiesIBA 08/2015 - 12/2007
2	Immunoglobulins (Immunoglobulin)IBA 10/2023 - 06/2003
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 06/2023 - 01/2023
2	mRNA VaccinesIBA 04/2023 - 01/2023
2	Monoclonal AntibodiesIBA 04/2023 - 01/2020
2	Nucleic AcidsIBA 10/2022 - 01/2020
2	AdrenomedullinIBA 08/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
2	C-Reactive ProteinIBA 02/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 01/2017
2	InterferonsIBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2016
2	AntioxidantsIBA 06/2020 - 01/2016
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2019
2	CholesterolIBA 11/2018 - 01/2016
2	TensinsIBA 03/2018 - 01/2016
2	Hormones (Hormone)IBA 01/2018 - 07/2004
2	B-Cell Activating FactorIBA 01/2018 - 12/2007
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2017 - 06/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2015
2	Cadherins (E-Cadherin)IBA 01/2016 - 01/2016
2	AdipokinesIBA 01/2015 - 04/2013
2	Anti-Citrullinated Protein AntibodiesIBA 11/2011 - 11/2010
2	Rheumatoid FactorIBA 11/2011 - 11/2010
2	Aurora KinasesIBA 06/2008 - 07/2006
1	ceftobiproleIBA 05/2023
1	Ampicillin (Omnipen)FDA LinkGeneric 05/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 06/2022

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2008
3	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2021
2	Noninvasive Ventilation 04/2022 - 01/2020
2	Liver Transplantation 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 10/2020 - 04/2017
1	Length of Stay 10/2022